Some of the most vital research at this juncture in the 21st century centers on cancer and oncology. The dissemination of information associated with oncological research is vital.
Established in 2010, Oncotarget is a leading journal that focuses on oncology and cancer research. Dove Press says that Oncotarget is a weekly publication that focuses on papers and articles about ongoing oncological research. All articles in Oncotarget are fully peer reviewed. The journal is published in the United States and is in English. It is available internationally and does accept papers and articles from credible, reputable researchers from around the world.
Oncotarget is overseen by Mikhail Blagosklonny and Andrei V. Gudkov, who serve as co-editors-in-chief. They both have extensive experience in oncology. They both as associated with the Roswell Park Cancer Institute.
The peer review process is important and underpins any piece published in the journal. The peer review process is overseen by a highly experienced editorial board. The editorial board is comprised of medical and healthcare professionals associated with academic institutions like Columbia University, John Hopkins University, and Harvard University.
Oncotarget is published online weekly. Although the focus is on ongoing oncological research, the journal also publishes peer reviewed papers and articles on research in associated and related areas.
According to Research Gate, Oncotarget is publication of Impact Journals. The publication is indexed through the Science Citation Index Expanded, Index Medicus/MEDLINE/PubMed, BIOSIS Previews, and Scopus.
A researcher or academic interested in making a submission to Oncotarget can find necessary information about the submission process at the journal’s website. In addition, information is available at the website regarding the peer review process at Oncotarget.